Low-Density Lipoprotein Cholesterol Targets in Patients With Coronary Heart Disease in Extremadura (Spain): LYNX Registry.
Background
Low-density lipoprotein cholesterol (LDL-C) contributes decisively to the development of cardiovascular disease (CVD). In the LYNX registry we determined the rate of achievement of the target value of LDL-C, the use of lipid-lowering therapy (LLT) and the predictive factors of not reaching the target in patients with stable coronary heart disease (CHD).


Methods
LYNX included consecutive patients with stable CHD treated at the University Hospital of Caceres, Extremadura (Spain) from September 2016 to September 2018, and those who must have an LDL-C target below 70 mg/dL according to the European Society of Cardiology (ESC) 2016 guidelines. The variables independently associated with the breach of the LDL-C objective were evaluated by multivariable logistic regression.


Results
A total of 674 patients with stable CHD were included. The average LDL-C levels were 68.3 ± 24.5 mg/dL, with 56.7% showing a level below 70 mg/dL. LLT was used by 96.7% of patients, 71.7% were treated with high-powered statins and 30.1% with ezetimibe. The risk of not reaching the target value of LDL-C was higher in women, in active smokers, and in those who had multivessel CHD or had atrial fibrillation. Patients with diabetes mellitus, those who took potent statins or co-administration treatment with ezetimibe were more likely to reach the target level of LDL-C.


Conclusions
The treatment of dyslipidemia in patients with chronic CHD remains suboptimal; however, an increasing number of very high-risk patients achieve the LDL-C objective, although there is still enormous potential to improve cardiovascular outcome through the use of more intensive LLT.
['Gomez-Barrado|Jose Javier|JJ|', 'Gomez-Turegano|Paula|P|', 'Ortiz-Cortes|Carolina|C|', 'Vega-Fernandez|Jorge|J|', 'Gomez-Turegano|Marta|M|', 'Garciperez de Vargas|Francisco Javier|FJ|', 'Lezcano Gort|Luis Enrique|LE|', 'Kounka|Zineb|Z|', 'Roque Rodriguez|Benjamin|B|', 'Chipayo Gonzales|David|D|', 'Perez-Espejo|Paloma|P|', 'Fernandez-Chamorro|Ana Isabel|AI|', 'Beltran Moreno|Maria|M|', 'Romero Castro|Maria Jose|MJ|', 'Mogollon Jimenez|Maria Victoria|MV|', 'Marcos Gomez|Gonzalo|G|', 'Porras Ramos|Yolanda|Y|']
Coronary heart disease Spain LDL-C Statin Dyslipidemia